Find, compare & contact
Taxoid xrp6258 (Cabazitaxel) API Manufacturers & Suppliers

Looking for Cabazitaxel API 183133-96-2?

Description:

Here you will find a list of producers, manufacturers and distributors of Cabazitaxel. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Cabazitaxel 

Synonyms:

Taxoid XRP6258 , Cabazitaxelum , XRP6258  

Cas Number:

183133-96-2 

DrugBank number:

DB06772 

Unique Ingredient Identifier:

51F690397J

Cabazitaxel is a type of Taxanes

Taxanes are a vital subcategory of pharmaceutical APIs (Active Pharmaceutical Ingredients) widely used in the treatment of various types of cancers. These organic compounds are derived from plants, with the most notable source being the Pacific yew tree (Taxus brevifolia). Taxanes exhibit potent anticancer properties, making them an essential component of many chemotherapy regimens.

One of the most well-known taxanes is paclitaxel, which acts by inhibiting cell division and promoting cell death in cancer cells. Paclitaxel is employed in the treatment of breast, lung, ovarian, and other types of cancers. Another taxane, docetaxel, shares similar mechanisms of action and is commonly used in the management of breast, prostate, and lung cancers.

The isolation and purification of taxanes from natural sources present significant challenges due to their low abundance. Consequently, pharmaceutical companies have developed synthetic methods to produce taxanes, ensuring a stable supply for medical purposes. These synthetic taxanes have shown comparable efficacy to their natural counterparts.

Taxanes are typically administered intravenously, allowing for optimal distribution throughout the body. They are formulated as injectable solutions containing taxane APIs along with other excipients to enhance solubility and stability. The dosage and administration of taxanes are carefully determined by healthcare professionals, taking into account factors such as the patient's condition and the specific cancer being treated.

In conclusion, taxanes are a crucial subcategory of pharmaceutical APIs used in cancer treatment. Their remarkable anticancer properties, derived from natural or synthetic sources, have revolutionized the management of various types of cancers, providing patients with improved therapeutic options.

Cabazitaxel (Taxanes), classified under Anticancer drugs

Anticancer drugs belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category designed specifically to combat cancer cells. These powerful medications play a crucial role in cancer treatment and are developed to target and destroy cancerous cells, preventing their growth and spread.

Anticancer drugs are classified based on their mode of action and can include various types such as chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormonal therapy drugs. Chemotherapy drugs work by interfering with the cell division process, thereby inhibiting the growth of cancer cells. Targeted therapy drugs, on the other hand, are designed to attack specific molecules or genes involved in cancer growth, minimizing damage to healthy cells. Immunotherapy drugs stimulate the body's immune system to recognize and destroy cancer cells. Hormonal therapy drugs are used in cancers that are hormone-dependent, such as breast or prostate cancer, to block the hormones that fuel cancer cell growth.

These APIs are typically synthesized through complex chemical processes in state-of-the-art manufacturing facilities. Stringent quality control measures ensure the purity, potency, and safety of these drugs. Anticancer APIs undergo rigorous testing and adhere to stringent regulatory guidelines before being approved for clinical use.

Due to their critical role in cancer treatment, anticancer drugs are in high demand worldwide. Researchers and pharmaceutical companies continually strive to develop new and more effective APIs in this category to enhance treatment outcomes and minimize side effects. The ongoing advancements in the field of anticancer drug development offer hope for improved cancer therapies and better patient outcomes.

• Shilpa Medicare Ltd from India, product country of origin India
• Shandong Octagon Chemicals Limited from China, product country of origin China
• Intas Pharma from United Kingdom, product country of origin Unknown
• TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
• Jiangxi Bioman Pharma Limited from China, product country of origin China
• Laurus Labs from India, product country of origin India
• Polymed Therapeutics from United States, product country of origin United States
• Shanghai Jinhe Bio-Pharma from China, product country of origin China
• Dr. Reddy's from India, product country of origin India
• Weijie Pharmaceuticals from China, product country of origin China
• Teva API from Israel, product country of origin Unknown
• Hetero Labs from India, product country of origin India
• Sanofi from France, product country of origin Unknown
• Indena from Italy, product country of origin France
• MSN Labs. from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.